New research shows astrocytes can remove Alzheimer’s-related amyloid-beta via autophagy, offering a promising new direction ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

In a breakthrough study, researchers have imaged a network of pathways in the human brain believed to clear waste proteins ...

Some of the most valuable health advancements in 2024 related to weight loss and metabolic health. New findings about ...

There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer's disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to ...

November 13, 2017 – Gates announces he is investing $50 million in the Dementia Discovery Fund, a private-public partnership focused on Alzheimer’s research ... January 23, 2023 – Gates’ fund ...

Discover the top biotech companies pioneering the next healthcare breakthroughs. Learn how innovative firms are ...

The Guardian Cap was born 14 years ago out of innovation and necessity. Both the NFL and NCAA had lagged at times in protecting its players' heads. At least the mounting lawsuits said as much.

In January 2023, lecanemab received accelerated ... the improvement awarded by lecanemab in Alzheimer’s disease is a breakthrough.” That sense of hesitation as to the transformative potential ...

We recently compiled a list of the 10 stocks that will make you rich in 5-10 years. In this article, we are going to take a ...

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

The 2006 paper had appeared to be an important breakthrough in our understanding of how Alzheimer’s works, providing the precise mechanisms ... Leqembi was approved in 2023. Donanemab now has FDA ...